National and Kapodistrian University of Athens
Δομική και λειτουργική ανάλυση των πρωτεϊνών BRCA1 και RAD51 σε βιοχημικό, βιοφυσικό και κυτταρικό επίπεδο στο σύστημα καρκίνου του μαστού - ωοθηκών
Abstract
dc:descriptionThe product of the brca1 gene is central to recombination reactions and thus contributes significantly to maintain the integrity of the genome. BRCA1 protein is strongly involved in DNA repair and cell cycle control through interactions with other partner proteins like BACH1, CtIP, p53 and Rad51. Mutations at the two C-terminal tandem (BRCT) repeats of BRCA1, disrupting BRCA1 interactions with other proteins, were identified in breast tumor patients. Biophysical analysis on the secondary structure, the thermodynamic stability and the modification in binding capacity of the recombinant and purified wt and mutated BRCT domains with BACH1 and CtIP have already been studied in vitro, by employing Circular Dichroism Spectroscopy (CD), Differential Scanning Microcalorimetry (DSC) and Isothermal Titration Calorimetry (ITC). Our currently available biophysical experiments clearly demonstrated that certain pathogenic mutations (V1696L, M1652I, M1775K, M1783T, V1809F, P1812A) of the BRCA1-BRCT cause changes in the stability of the domain and influence the binding affinities with synthetic phosphopeptides, corresponding to BACH1 and CtIP binding sites. Moreover based on the interaction parameters of the BRCT-wt and the six variants of this study with pBACH1 and pCtIP were draw the following conclusions: (a) the BRCT-wt bind to both pBACH1 and pCtIP with binding parameters identical to those previously published, (b) in all cases thermally denatured proteins show no binding, (c) the mutants M1783T, P1812A were found to bind to both phosphopeptides, (d) the mutant V1696L binds only to pBACH1, (e) the mutants M1652I, M1775K, V1809F show neither binding to pBACH1 nor to pCtIP like M1775R and R1699W, previously published, (f) the BRCT-wt show stronger affinity with pBACH1 compare with pCtIP. In all CD far-UV spectra of all variants is clear that they perfectly overlap with the corresponding spectrum of the BRCT-wt. In order to investigate the effects of these pathogenic mutations of BRCA1-BRCT in protein’s localization fused GFP-BRCA1 mutants demonstrated and expressed in MCF7 cells. Analysis of the intracellular localization, as well as the co-localization-interactions with p53 and Rad51, were performed with fluorescence microscopy. The experiments in MCF7 have shown a dramatic alteration on their intracellular localization as well as the co-localization with p53, Rad51. The experiments were performed with use of fluorescence microscopy.The current preliminary experiments indicate that pathogenic mutations of BRCT domain with structurally unstable feature in vitro, affect the intracellular localization of the BRCA1 protein and its “cross-talk” with other protein partners. The anticipated results will support the elucidation of the effect of various pathogenic BRCT mutations on the miss-function of BRCA1 nuclear DNA repair replication and cell cycle control at
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Drikos, Ioannis
- Δρίκος, Ιωάννης
Subjects
dc:subject × 19- Καρκίνος μαστού
- Επιδιόρθωση γενώματος
- Ομόλογος ανασυνδυασμός
- Πρωτεϊνική ανάλυση
- Ανάλυση παθογόνων μεταλλάξεων
- BRCA1
- BRCT
- BACH1
- CtIP
- Breast cancer
- DNA repair
- Homologus recombination
- Protein analysis
- Protein interactions
- Analysis of pathogenic mutations
- Φυσικές Επιστήμες
- Βιολογία
- Natural Sciences
- Biological Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19701